Boston Scientific Corp. said it is recalling 200 of its recently approved drug-coated coronary stents because of a malfunction that has been blamed for at least one death. The devicemaker said the malfunction involves a small fraction of the nearly half-million stents implanted in heart patients. It blamed the problem on a manufacturing defect that has since been fixed. The defect can prevent a tiny balloon from deflating after it is used to expand the stent. The company said it reported one death and 16 serious injuries from such deflation failures to the Food and Drug Administration. But the company said it found the problem in only two lots shipped since the stent won FDA clearance for U.S. sales on March 4. -- by the Associated Press
Boston Scientific recalls 200 stents after death
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You